Companion Diagnostics Market (Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Upcoming SlideShare
Loading in...5
×

Like this? Share it with your network

Share

Companion Diagnostics Market (Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • 496 views
Uploaded on

...


Transparency Market Research published new market report "Companion Diagnostics Market (Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" This report studies the global market for companion diagnostics from two perspectives – companion diagnostics by indication and by geography. The market for companion diagnostics by indication includes sub-segments such as breast cancer, lung cancer, colorectal cancer, gastric cancer, melanoma and others (HIV, Thalassemia). By geography, the companion diagnostics market has been divided into four regions, namely, North America, Europe, Asia-Pacific and RoW. Market size and forecast for each segment and sub-segment has been provided for the period 2011 to 2019 in terms of USD million, with 2012 as the base year.

Browse the report With Full TOC at http://www.transparencymarketresearch.com/companion-diagnostics-market.html

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
496
On Slideshare
496
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
2
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. REPORT DESCRIPTION Companion Diagnostics Market is Expected to Reach USD 5.6 Billion Globally in 2019: Transparency Market Research Transparency Market Research published new market report “Companion Diagnostics Market (Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global companion diagnostics market was valued at USD 1.8 billion in 2012 and is expected to grow at a CAGR of 18.1% from 2013 to 2019, to reach an estimated value of USD 5.6 billion in 2019. Companion diagnostics are the tests or assays which assist physicians in making efficient treatment decisions depending on the patient response to the ongoing treatment. These tests are developed either once the drug is commercialized or along with the drug in development. The diagnostic test acts as a companion to the drug under investigation and ensures the commercialization of a safer and efficient targeted therapeutic in a very cost effective manner. The most important factors favoring growth of the global companion diagnostics market include the increasing focus of pharmaceutical manufacturers on cost reduction in drug discovery and development, and the rising demand for targeted therapies. Transparency Market Research Companion Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019 Single User License: US $ 4595 Multi User License: US $ 7595 Corporate User License: US $ 10595 Buy Now Request Sample Published Date: Aug 2013 84 Pages Report
  • 2. Also, continuous exploration of biomarkers and advances in diagnostic technologies will drive the growth and acceptance of companion diagnostics worldwide. Factors such as lack of compact regulatory guidelines for the development and commercialization of companion diagnostics, high cost of procedures, lengthy developmental and approval phases, and lack of proper reach and availability (particularly in the low income countries) are expected to hamper the ready acceptance of companion diagnostics. Currently, many in vitro diagnostics companies are focusing on the development of accurate and reliable companion diagnostics for various biomarkers. Pharmaceutical companies are either focusing on in-house development of companion diagnostics or development in collaboration with diagnostics companies. This strategy focusing on the co-development of a drug and its companion diagnostic will prove to be advantageous over the conventional development process occurring in isolation. The global companion diagnostics market can be categorized by tests for various indications and geography. Companion diagnostics market for breast cancer was the most prominent segment of the market in 2012 by revenue. Extensive research on breast cancer biomarkers and a paradigm shift towards personalized medicine will continue to propel the adoption of breast cancer companion diagnostics. However, another attractive segment of this market is that of lung cancer companion diagnostics, with the discovery of lung cancer specific biomarkers and an elaborate pipeline of related companion diagnostics for the same. It is estimated that the global market for lung cancer companion diagnostics will grow at a CAGR of over 20% from 2013 to 2019. At a regional level, North America was the largest market in 2012 for companion diagnostics, followed by the European region. The favorable healthcare policies, large consumer base, high disposable incomes, increased awareness, presence of suitable infrastructure facilities and ready acceptance of novel approaches in medicine will propel rapid development of companion diagnostics in the North American market. The Asia-Pacific and RoW regions are expected to experience commendable growth by 2019 due to the huge untapped potential, rising disposable incomes and continuous improvements in healthcare infrastructure. Related & Recently Published Reports by Transparency Market Research In Vitro Diagnostics Market: http://www.transparencymarketresearch.com/in-vitro- diagnostic-tests.html Pain Management Devices Market: http://www.transparencymarketresearch.com/pain- management-drugs-devices.html Microscopy Devices Market: http://www.transparencymarketresearch.com/microscopy- market.html The companion diagnostics market is characterized by the presence of established diagnostics manufacturers as well as small players solely operating in this market. The major companies competing in this market are Roche Holdings AG, Qiagen N.V., Abbott
  • 3. Laboratories, Agilent Technologies, Inc., Genomic Health, Inc., GE Healthcare Ltd., Life Technologies Corporation, and Agendia N.V. The global companion diagnostics market is segmented as follows: Companion Diagnostics Market, by Indications  Breast Cancer  Lung Cancer  Colorectal Cancer  Gastric Cancer  Melanoma  Others (HIV, Thalassemia) Companion Diagnostics Market, by Geography  North America  Europe  Asia-Pacific  Rest of the World (RoW) TABLE OF CONTENTS Chapter 1 Introduction 1.1 Report Description 1.2 Research Methodology 1.3 Market Segmentation 1.4 List Of Abbreviations Chapter 2 Executive Summary
  • 4. Browse the full report at http://www.transparencymarketresearch.com/companion-diagnostics- market.html Chapter 3 Market Overview 3.1 Introduction 3.2 Market Drivers 3.2.1 Rising Need For Companion Diagnostics Along With Targeted Therapies 3.2.2 Increasing Demand As Well As Developmental Efforts Towards Personalized Medicine 3.2.3 The Pharmacoeconomic Advantage: Reduced Drug Development Costs 3.2.4 Increasing Cancer Incidence Worldwide 3.2.5 Impact Analysis Of Market Drivers 3.3 Market Restraints 3.3.1 Effect Of Influence Of Advocacy Groups And Clinical Societies 3.3.2 Prolonged Developmental And Approval Phases 3.3.3 Impact Analysis Of Market Restraints 3.4 Market Opportunities 3.4.1 Expansion Into Newer Indication Areas 3.5 Porter’s Five Force Analysis: Global Companion Diagnostics Market 3.5.1 Bargaining Power Of Buyers 3.5.2 Bargaining Power Of Suppliers 3.5.3 Threat Of Substitutes 3.5.4 Threat Of New Entrants 3.5.5 Competitive Rivalry 3.6 Market Attractiveness Analysis: Global Companion Diagnostics Market, By Geography, 2012
  • 5. Chapter 4 Companion Diagnostics Market, By Indications, 2011 - 2019 (USD Million) 4.1 Introduction 4.1.1 Comparative Analysis: Global Companion Diagnostics Market, By Indication, 2012 & 2019 (Value %) 4.1.2 Breast Cancer 4.1.3 Lung Cancer 4.1.4 Colorectal Cancer 4.1.5 Gastric Cancer 4.1.6 Melanoma 4.1.7 Others (HIV, Thalassemia) Chapter 5 Companion Diagnostics Market, By Geography, 2011 - 2019 (USD Million) 5.1 Overview 5.1.1 Comparative Analysis: Global Companion Diagnostics Market, By Geography, 2012 & 2019 (Value %) 5.2 North America 5.2.1 North America Companion Diagnostics Market Size And Forecast, 2011 - 2019 (USD Million) 5.3 Europe 5.3.1 Europe Companion Diagnostics Market Size And Forecast, 2011 - 2019 (Usd Million) 5.4 Asia-Pacific 5.4.1 Asia-Pacific Companion Diagnostics Market Size And Forecast, 2011 - 2019 (USD Million) 5.5 Rest Of The World (Row) 5.5.1 Row Companion Diagnostics Market Size And Forecast, 2011 - 2019 (USD Million)
  • 6. Browse the full report at http://www.transparencymarketresearch.com/companion-diagnostics- market.html Chapter 6 Competitive Landscape 6.1 Market Share By Key Players, 2012 (%) Chapter 7 Recommendations 7.1 Changing Business Models of Pharmaceutical and Diagnostics Manufacturers 7.2 Investing in Emerging Economies Chapter 8 Company Profiles 8.1 Abbott Laboratories 8.1.1 Company Overview 8.1.2 Financial Overview 8.1.3 Product Portfolio 8.1.4 Business Strategies 8.1.5 Recent Developments 8.2 Agendia N.V. 8.2.1 Company Overview 8.2.2 Product Portfolio 8.2.3 Business Strategies 8.2.4 Recent Developments 8.3 Agilent Technologies, Inc., 8.3.1 Company Overview 8.3.2 Financial Overview
  • 7. 8.3.3 Product Portfolio 8.3.4 Business Strategies 8.3.5 Recent Developments 8.4 Biogenex Laboratories, Inc. 8.4.1 Company Overview 8.4.2 Product Portfolio 8.4.3 Business Strategies 8.4.4 Recent Developments 8.5 Ge Healthcare Ltd. 8.5.1 Company Overview 8.5.2 Financial Overview 8.5.3 Product Portfolio 8.5.4 Business Strategies 8.5.5 Recent Developments 8.6 Genomic Health, Inc. 8.6.1 Company Overview 8.6.2 Financial Overview 8.6.3 Product Portfolio 8.6.4 Business Strategies 8.6.5 Recent Developments 8.7 Laboratory Corporation Of America Holdings (Labcorp) 8.7.1 Company Overview 8.7.2 Financial Overview 8.7.3 Product Portfolio 8.7.4 Business Strategies
  • 8. 8.7.5 Recent Developments 8.8 Life Technologies Corporation 8.8.1 Company Overview 8.8.2 Financial Overview 8.8.3 Product Portfolio 8.8.4 Business Strategies 8.8.5 Recent Developments 8.9 Qiagen N.V. 8.9.1 Company Overview 8.9.2 Financial Overview 8.9.3 Product Portfolio 8.9.4 Business Strategies 8.9.5 Recent Developments 8.10 Resonance Health Analysis Services Pty Ltd. 8.10.1 Company Overview 8.10.2 Product Portfolio 8.10.3 Business Strategies 8.10.4 Recent Developments 8.11 Roche Holdings Ag 8.11.1 Company Overview 8.11.2 Financial Overview 8.11.3 Product Portfolio 8.11.4 Business Strategies 8.11.5 Recent Developments 8.12 Siemens Healthcare
  • 9. 8.12.1 Company Overview 8.12.2 Financial Overview 8.12.3 Product Portfolio 8.12.4 Business Strategies 8.12.5 Recent Developments About Us: Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge. Contact: Transparency Market Research 90 State Street, Suite 700, Albany NY – 12207, United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/ Browse the full report at http://www.transparencymarketresearch.com/companion-diagnostics- market.html